MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$6,402K
Net Income
-$2,790K
Net Profit Margin
-43.58%
EPS
-$0.05
Unit: Thousand (K) dollars
Revenue Breakdown
US
Europe
Asia Pacific
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-04-30
Revenues
6,402
Selling, general and administrative
4,904
Research and development
504
Legal and related expense, net
465
Cost of revenues
3,755
Cost of revenues inventory provision
163
Total operating costs and expenses
9,791
Operating loss
-3,389
Other
123
Interest, net
384
Foreign exchange (loss) gain
508
Total other income (expense), net
1,015
Loss before income taxes
-2,374
Net loss from continuing operations
-2,374
Net loss from discontinued operations
-416
Net loss
-2,790
Basic EPS
-0.05
Diluted EPS
-0.05
Basic Average Shares
52,403
Diluted Average Shares
52,403
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$2,790K
Net loss from
continuing operations
-$2,374K
Net loss from
discontinued operations
-$416K
Foreign exchange (loss)
gain
$508K
Interest, net
$384K
Other
$123K
Loss before income
taxes
-$2,374K
Total other income
(expense), net
$1,015K
US
$4,054K
Europe
$1,706K
Asia Pacific
$642K
Operating loss
-$3,389K
Revenues
$6,402K
Total operating costs
and expenses
$9,791K
Selling, general and
administrative
$4,904K
Cost of revenues
$3,755K
Research and development
$504K
Legal and related
expense, net
$465K
Cost of revenues
inventory provision
$163K
Buy us a coffee
ENZO BIOCHEM INC (ENZB)
ENZO BIOCHEM INC (ENZB)